Related Experiment Videos
Frontotemporal dementias: clinical features and management
1Department of Neurology, University of Southern California, Downey, CA, USA. tchow@usc.edu
Seminars in Clinical Neuropsychiatry
|February 5, 2003
Summary
Frontotemporal lobar degeneration (FTLD) presents distinct clinical features and behavioral changes compared to Alzheimer's disease. While no cure exists, pharmacotherapy can manage FTLD symptoms effectively.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Frontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disorder.
- FTLD is often misdiagnosed, presenting challenges in differentiating it from Alzheimer's disease.
- Understanding FTLD's unique clinical profile is crucial for timely diagnosis and management.
Purpose of the Study:
- To review the clinical characteristics that distinguish FTLD from Alzheimer's disease.
- To outline current therapeutic interventions for managing FTLD symptoms.
- To provide a comprehensive overview of FTLD for clinicians and researchers.
Main Methods:
- Literature review of clinical studies and therapeutic trials on FTLD.
- Comparative analysis of clinical features between FTLD and Alzheimer's disease.
- Synthesis of evidence regarding pharmacotherapy for behavioral disturbances in FTLD.
Main Results:
- FTLD exhibits distinct clinical features, particularly mood and behavioral disturbances, differentiating it from Alzheimer's disease.
- No disease-modifying treatments are currently available for FTLD.
- Symptomatic pharmacotherapy is effective in managing significant mood and behavioral symptoms.
Conclusions:
- Accurate differentiation of FTLD from other dementias, especially Alzheimer's disease, is essential.
- Current management of FTLD focuses on symptomatic relief, particularly for behavioral and mood disturbances.
- Further research into disease-modifying therapies for FTLD is warranted.